Utility of the Citrobacter rodentium infection model in laboratory mice

Current Opinion in Gastroenterology

Volumn 24, Issue 1, 2008, Pages 32-37

  Borenshtein, Diana ^a   McBee, Megan E ^a   Schauer, David B ^a  

^a Massachusetts Institute of Technology   (United States)

Author keywords

Acute diarrheal illness; Citrobacter freundii biotype 4280; Colitis; Enterobacteriaceae infections; Transmissible murine colonic hyperplasia

Indexed keywords

ADAPTIVE IMMUNITY; CITROBACTER RODENTIUM; COLITIS; COLON MUCOSA; DIARRHEA; DISEASE COURSE; EPITHELIUM HYPERPLASIA; EXPERIMENTAL MOUSE; GASTROENTERITIS; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; REVIEW;

ANIMALS; CITROBACTER RODENTIUM; DIARRHEA; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; MICE; MICE, INBRED STRAINS; PROBIOTICS; VIRULENCE;

EID: 36549048075     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282f2b0fb     Document Type: Review

References (46)

1. Luperchio SA, Schauer DB. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 2001; 3:333-340.
2. Mundy R, MacDonald TT, Dougan G, et al. Citrobacter rodentium of mice and man. Cell Microbiol 2005; 7:1697-1706.
3. Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci 2006; 1072:28-38.
4. Mundy R, Girard F, FitzGerald AJ, Frankel G. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol Lett 2006; 265:126-132.
5. Klapproth JM, Sasaki M, Sherman M, et al. Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect Immun 2005; 73:1441-1451.
6. Savkovic SD, Villanueva J, Turner JR, et al. Mouse model of enteropathogenic Escherichia coli infection. Infect Immun 2005; 73:1161-1170.
7. Tatsuno I, Mundy R, Frankel G, et al. The lpf gene cluster for long polar fimbriae is not involved in adherence of enteropathogenic Escherichia coli or virulence of Citrobacter rodentium. Infect Immun 2006; 74:265-272.
8. Vlisidou I, Marches O, Dziva F, et al. Identification and characterization of EspK, a type III secreted effector protein of enterohaemorrhagic Escherichia coli O157:H7. FEMS Microbiol Lett 2006; 263:32-40.
9. Li M, Rosenshine I, Yu HB, et al. Identification and characterization of NleI, a new non-LEE-encoded effector of enteropathogenic Escherichia coli (EPEC). Microbes Infect 2006; 8:2890-2898.
10. Mundy R, Pickard D, Wilson RK, et al. Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium. Mol Microbiol 2003; 48:795-809.
11. Kelly M, Hart E, Mundy R, et al. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun 2006; 74:2328-2337.
12. ••]).
13. Simpson N, Shaw R, Crepin VF, et al. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea. Mol Microbiol 2006; 60:349-363. An elegant study using yeast two-hybrid to identify the EPEC T3SS effector Map as a binding partner for EBP50 (NHERF1), which also clarifies the role of Map in ultrastructural changes (brush border effacement), decreased barrier function, and diarrhea in vitro and in vivo.
14. Wickham ME, Lupp C, Mascarenhas M, et al. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 2006; 194:819-827.
15. Wang Y, Xiang GS, Kourouma F, Umar S. Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation. Br J Pharmacol 2006; 148:814-824.
16. Umar S, Wang Y, Morris AP, Sellin JH. Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia. Am J Physiol Gastrointest Liver Physiol 2007; 292:G599-G607. This paper characterizes the in-vivo signaling events associated with epithelial hyperplasia caused by C. rodentium infection in Swiss Webster mice.
17. Barthold SW, Osbaldiston GW, Jonas AM. Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab Anim Sci 1977; 27:938-945.
18. Borenshtein D, Nambiar PR, Groff EB, et al. Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect Immun 2007; 75:3271-3281. This paper documents fatal C. rodentium infection and colitis in adult inbred FVB mice and goes on to show that fluid therapy protects against mortality and allows for long-term resolution of colonic lesions. These results implicate alterations in fluid balance and electrolytes in the pathogenesis of fatal C. rodentium infection.
19. Vallance BA, Deng W, Jacobson K, Finlay BB. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 2003; 71:3443-3453.
20. Khan MA, Ma C, Knodler LA, et al. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun 2006; 74:2522-2536.
21. Lebeis SL, Bommarius B, Parkos CA, et al. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol 2007; 179:566-577. This paper shows a critical role for TLR signaling in protective host responses that lead to clearance of C. rodentium infection and resolution of colitis.
22. Luperchio SA, Newman JV, Dangler CA, et al. Citrobacter rodentium, the causative agent of transmissible murine colonic hyperplasia, exhibits clonality: synonymy of C. rodentium and mouse-pathogenic Escherichia coli. J Clin Microbiol 2000; 38:4343-4350.
23. MacLean LL, Perry MB. Structural studies on the O-polysaccharide of the lipopolysaccharide produced by Citrobacter rodentium (ATCC 51459). Eur J Biochem 2001; 268:5740-5746.
24. Bry L, Brenner MB. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 2004; 172:433-441.
25. Bry L, Brigl M, Brenner MB. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect Immun 2006; 74:673-681.
26. Maaser C, Housley MP, Iimura M, et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun 2004; 72:3315-3324.
27. Simmons CP, Clare S, Ghaem-Maghami M, et al. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun 2003; 71:5077-5086.
28. Vallance BA, Deng W, Knodler LA, Finlay BB. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect Immun 2002; 70:2070-2081.
29. Yoshida M, Kobayashi K, Kuo TT, et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 2006; 116:2142-2151. This paper shows that FcRn transports IgG across the epithelial barrier, providing insight into the mechanism by which humoral immunity mediates clearance of C. rodentium infection.
30. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the Th17 lineage. Nature 2006; 441:231-234. This paper shows that Th17 immune responses predominate early in C. rodentium infection, and uses IL-23p19-deficient mice to uncover a crucial role for IL-23 in controlling infection that is necessary for survival.
31. Chen CC, Louie S, Shi HN, Walker WA. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res 2005; 58:1185-1191.
32. D'Arienzo R, Maurano F, Mazzarella G, et al. Bacillus subtilis spores reduce susceptibility to Citrobacter rodentium-mediated enteropathy in a mouse model. Res Microbiol 2006; 157:891-897.
33. Johnson-Henry KC, Nadjafi M, Avitzur Y, et al. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis 2005; 191:2106-2117.
34. Chen CC, Louie S, McCormick B, et al. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect Immun 2005; 73:5468-5481.
35. Chen CC, Louie S, McCormick BA, et al. Helminth-primed dendritic cells alter the host response to enteric bacterial infection. J Immunol 2006; 176:472-483. This paper characterizes crosstalk between innate and adaptive immunity and shows how dysregulation of innate immune cell function in concurrent infection can affect disease outcome.
36. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003; 81:197-204.
37. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367:1747-1757.
38. Guttman JA, Li Y, Wickham ME, et al. Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol 2006; 8:634-645. The paper documents in-vivo redistribution of claudins 1, 3, and 5 in response to C. rodentium infection resulting in intestinal barrier dysfunction and diarrhea. These changes are dependent on EspF, but not Map.
39. Guttman JA, Samji FN, Li Y, et al. Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo. Infect Immun 2006; 74:6075-6084. This paper shows that mucosal inflammation is not required for C. rodentium-induced alterations in tight junctions.
40. Guttman JA, Kazemi P, Lin AE, et al. Desmosomes are unaltered during infections by attaching and effacing pathogens. Anat Rec (Hoboken) 2007; 290:199-205.
41. Guttman JA, Samji FN, Li Y, et al. Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell Microbiol 2007; 9:131-141. By characterizing EspF and EspG-dependent redistribution of water channels AQP2 and AQP3 following C. rodentium infection, this paper makes a substantial contribution to our understanding of the mechanistic basis of infectious diarrhea.
42. O'Hara JR, Skinn AC, MacNaughton WK, et al. Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 2006; 8:646-660. This paper shows changes in the structure and function of the enteric nervous system during C. rodentium infection, leading to alterations in signaling, gut motility, and secretion. A role for adaptive immunity in these changes was established by using severe combined immunodeficient (SCID) mice.
43. •] are the first to explore the effects of acute C. rodentium infection on xenobioticmetabolism, by characterizing hepatic and renal expression of P450s, UGTs, cytokines, acute phase proteins, and nuclear receptors. Changes were compared with systemic administration of endotoxin.
44. •] are the first to explore the effects of acute C. rodentium infection on xenobiotic metabolism, by characterizing hepatic and renal expression of P450s, UGTs, cytokines, acute phase proteins, and nuclear receptors. Changes were compared with systemic administration of endotoxin.
45. Williams AE, Edwards L, Hussell T. Colonic bacterial infection abrogates eosinophilic pulmonary disease. J Infect Dis 2006; 193:223-230. This paper shows that C. rodentium infection in the colon modulates the outcome of fungal infection in the lung. Th1 immunity ameliorates C. neoformans disease, providing an exciting example of immune crosstalk between mucosal site that may have broad implications for a variety of infectious diseases.
46. Schauer DB, Falkow S. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia. Infect Immun 1993; 61:4654-4661.